Article
Just as patients suffering from body dysmorphic disorder (BDD) are out of touch with reality, doctors' assumptions regarding this disease often miss the mark, say some dermatologists.
The Weekly Roundup: October 7-11
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Safe and Effective: Upadacitinib Shows Promise in PN Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial